Association of PIP5K2A with schizophrenia: A study in an Indonesian family sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 7, 2008, Pages 1310-1313

  Saggers Gray, L ^a,b   Heriani, H ^c   Handoko, H Y ^d   Irmansyah, I ^c   Kusumawardhani, A A A A ^c   Widyawati, I ^c   Amir, N ^c   Nasrun, M W S ^c   Schwab, S G ^a,b,e,g   Wildenauer, D B ^b,f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF INDONESIA   (Indonesia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f GRAYLANDS HOSPITAL   (Australia)

^g NONE   (Australia)

Author keywords

Association; Genetic heterogeneity; Indonesia; PIP5K2A; Schizophrenia

Indexed keywords

PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE TYPE 2ALPHA; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; UNCLASSIFIED DRUG;

ARTICLE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INDONESIA; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; FAMILY HEALTH; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDONESIA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SIBLINGS;

EID: 55349132386     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30736     Document Type: Article

References (32)

1. Abou Jamra RA, Klein K, Villela AW, Becker T, Schulze TG, Schmael C, Deschner M, Klopp N, Illig T, Propping P, et al. 2006. Association study between genetic variants at the PIP5K2A gene locus and schizophrenia and bipolar affective disorder. Am J Med Genet Part B 141:663-665.
2. Bakker SC, Hoogendoorn MLC, Hendriks J, Verzijlbergen K, Caron S, Verduijn W, Selten JP, Pearson PL, Kahn RS, Sinke RJ. 2006. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav 6:113-119.
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
4. Becker T, Knapp M. 2004a. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 27(1):21-32.
5. Becker T, Knapp M. 2004b. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 75(4):561-570.
6. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW, Wellman N, Loftus J, Nanthakumar B, Razi K, et al. 2002. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 159(5):803-812.
7. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, et al. 1998. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 81(4):290-295.
8. Foroud T, Castelluccio PF, Koller DL, Edenberg HJ, Miller M, Bowman E, Rau NL, Smiley C, Rice JP, Goate A, et al. 2000. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. Am J Med Genet 96(1):18-23.
9. Gardner M, Gonzalez-Neira A, Lao O, Calafell F, Bertranpetit J, Comas D. 2006. Extreme population differences across Neuregulin 1 gene, with implications for association studies. Mol Psychiatry 11(1):66-75.
10. Hallcher LM, Sherman WR. 1980. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 255(22):10896-11901.
11. Holliday E, Mowry B, Chant D, Nyholt D. 2005. The importance of modelling heterogeneity in complex disease: Application to NIMH Schizophrenia Genetics Initiative data. Hum Genet 117(2-3):160-167.
12. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Evans M, Carr V, Morgan V, Korten A, Harvey C. 2000. Psychotic disorders in urban areas: An overview of the study on low prevalence disorders. Aust N Z J Psychiatry 34(2):221-236.
13. Knapp M, Becker T. 2003. Family-based association analysis with tightly linked markers. Hum Hered 56(1-3):2-9.
14. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, Pulver AE, Laurent C, Kendler KS, Walsh D, et al. 2000. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: Schizophrenia linkage collaborative group III. Am J Hum Genet 67(3):652-663.
15. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33(2):177-182.
16. Maxwell M. 1992. Manual for the family interview for genetic studies (FIGS). Clinical Neurogenetics Branch, Intramural Research Program. National Institute of Mental Health.
17. Morar B, Schwab SG, Albus M, Maier W, Lerer B, Wildenauer DB. 2007. Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia. Am J Med Genet Part B 144B(3):318-324.
18. Munafo MR, Thiselton DL, Clark TG, Flint J. 2006. Association of the NRG1 gene and schizophrenia: a meta analysis. Mol Psychiatry 11:539-546.
19. Purcell S, Cherny SS, Sham. PC. 2003. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1):149-150.
20. Rameh LE, Tolias KF, Duckworth BC, Cantley LC. 1997. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature 390(6656):192-196.
21. Rice JP, Goate A, Williams JT, Bierut L, Dorr D, Wu W, Shears S, Gopalakrishnan G, Edenberg HJ, Foroud T, et al. 1997. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 1, 6, 8, 10,and 12. Am J Med Genet 74(3):247-253.
22. Risch N. 1990. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet Epidemiol 7(1):3-16 discussion 17-45.
23. Risch N, Burchard E, Ziv E, Tang. H. 2002. Categorization of humans in biomedical research: Genes, race and disease. Genome Biol 3(7): comment 2007.
24. Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K, Segman R, Borrman M, Dreikorn B, Lichtermann D, et al. 1998. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 81(4):302-3027.
25. Schwab SG, Knapp M, Sklar P, Eckstein GN, Sewekow C, Borrmann-Hassenbach M, Albus M, Becker T, Hallmayer JF, Lerer B, et al. 2006. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol Psychiatry 11:837-846.
26. Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M, Harwood AJ, Belmaker RH, Greenberg ML, Agam. G. 2004. Valproate decreases inositol biosynthesis. Biol Psychiatry 56(11):868-874.
27. Stopkova P, Saito T, Fann CS, Papolos DF, Vevera J, Paclt I, Zukov I, Stryjer R, Strous RD, Lachman HM. 2003. Polymorphism screening of PIP5K2A: A candidate gene for chromosome 10p-linked psychiatric disorders. Am J Med Genet Part B 123B(1):50-58.
28. Stopkova P, Vevera J, Paclt I, Zukov I, Papolos DF, Saito T, Lachman HM. 2005. Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia. Psychiatr Genet 15(3):223-227.
29. Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr C, Webb BT, O'Neill FA, Walsh D, Kendler KS. 1998. A schizophrenia locusmay be located in region 10p15-p11. Am J Med Genet 81(4):296-301.
30. WHO. 1996. Personal and psychiatric history schedule. Geneva: World Health Organisation.
31. Wolfson M, Bersudsky Y, Zinger E, Simkin M, Belmaker RH, Hertz L. 2000. Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. Brain Res 855(1):158-161.
32. Zhao H, Zhang S, Merikangas KR, Trixler M, Wildenauer DB, Sun F, Kidd. KK. 2000. Transmission/disequilibrium tests using multiple tightly linked markers. Am J Hum Genet 67(4):936-946.